The regulatory role of dietary ω-3 essential fatty acids on oxidant/antioxidant balance in rat hippocampus

被引:29
作者
Sarsimaz, M
Songur, A
Kus, I
Ozyurt, B
Gulec, M
Sogut, S
Ilhan, A
Akyol, O
机构
[1] Firat Univ, Dept Anat, Fac Med, TR-23119 Elazig, Turkey
[2] Afyon Kocatepe Univ, Fac Med, Dept Anat, Afyon, Turkey
[3] Inonu Univ, Fac Med, Dept Biochem, Malatya, Turkey
[4] Inonu Univ, Fac Med, Dept Neurol, Malatya, Turkey
[5] Mustafa Kemal Univ, Fac Med, Dept Biochem, Hatay, Turkey
关键词
omega-3 essential fatty acids; superoxide dismutase; xanthine oxidase; lipid peroxidation; nitric oxide; schizophrenia therapy;
D O I
10.1002/nrc.10087
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Omega-3 essential fatty acids (omega-3 EFA) contains eicosapentaenoic acid and docosahexaenoic acid (DHA). DHA is one of the building structures of membrane phospholipids of brain and necessary for continuity of neuronal functions. omega-3 EFA has been suggested to be protective against neuropsychiatric disorders including schizophrenia. This study proposed to assess the changes in superoxide dismutase (SOD), xanthine oxidase (XO), malondialdehyde (MDA), and nitric oxide (NO) in the hippocampus of rats fed with omega-3 EFA diet (0.4 g/kg/day) for 30 days. Eight control rats and nine rats fed with omega-3 EFA were decapitated under ether anesthesia, and hippocampus was removed immediately. Rats treated with omega-3 EFA had significantly lower XO activity (p<0.002) and NO level (p<0.0001) whereas higher SOD activity (p<0.002) and MDA levels (p<0.019) than the control rats. These results suggest that the dietary omega-3 EFA may act on the oxidant/antioxidant parameters in hippocampus. On the other hand, although the mechanism is not clear, omega-3 EFA may enhance one of the most important antioxidant enzymes, SOD. Further studies are needed to clarify the molecular mechanism involved and the therapeutic implication of omega-3 EFA in animal psychosis models and clinical studies.
引用
收藏
页码:114 / 123
页数:10
相关论文
共 27 条
[1]   Decrease in neuron size in docosahexaenoic acid-deficient brain [J].
Ahmad, A ;
Moriguchi, T ;
Salem, N .
PEDIATRIC NEUROLOGY, 2002, 26 (03) :210-218
[2]  
Akyol O, 2002, EUR PSYCHIAT, V17, p75S
[3]   ACTIVITIES OF FREE-RADICAL AND DNA TURN-OVER ENZYMES IN CANCEROUS AND NON-CANCEROUS HUMAN BRAIN-TISSUES [J].
AKYOL, O ;
ARSLANOGLU, R ;
DURAK, I .
REDOX REPORT, 1995, 1 (04) :255-259
[4]   The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance [J].
Akyol, Ö ;
Herken, H ;
Uz, E ;
Fadillioglu, E ;
Ünal, S ;
Sögüt, S ;
Özyurt, H ;
Savas, HA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05) :995-1005
[5]   Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients [J].
Arvindakshan, M ;
Sitasawad, S ;
Debsikdar, V ;
Ghate, M ;
Evans, D ;
Horrobin, DF ;
Bennett, C ;
Ranjekar, PK ;
Mahadik, SP .
BIOLOGICAL PSYCHIATRY, 2003, 53 (01) :56-64
[6]  
CORTAS NK, 1990, CLIN CHEM, V36, P1440
[7]   NO synthase and xanthine oxidase activities of rabbit brain [J].
Deliconstantinos, G ;
Villiotou, V .
NEUROCHEMICAL RESEARCH, 1996, 21 (01) :51-61
[8]   REACTIVE OXYGEN SPECIES AND THE CENTRAL-NERVOUS-SYSTEM [J].
HALLIWELL, B .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (05) :1609-1623
[9]   Neuroimaging studies of the hippocampus in schizophrenia [J].
Heckers, S .
HIPPOCAMPUS, 2001, 11 (05) :520-528
[10]   Hippocampal neurons in schizophrenia [J].
Heckers, S ;
Konradi, C .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (5-6) :891-905